"目錄號: HY-13718
Oglufanide能夠抑制VEGF,也能夠抑制血管生成奖慌。
相關(guān)產(chǎn)品
Sorafenib-BIBF 1120-SU5416-Regorafenib-Ponatinib-Sunitinib-Cabozantinib-Vandetanib-Lenvatinib-Apatinib-Pazopanib-SU 5402-Foretinib-Axitinib-E-3810-
生物活性
Description
Oglufanide inhibits vascular endothelial growth factor (VEGF), which may inhibit angiogenesis.This agent has also been reported to stimulate the immune response to hepatitic C virus and intracellular bacterial infections.
Clinical Trial
University of Southern California-National Cancer Institute (NCI)
Ovarian Cancer
February 1999
Phase 1
University of Southern California-National Cancer Institute (NCI)
Colorectal Cancer
November 1999
Phase 2
Cytran-National Cancer Institute (NCI)
Ovarian Cancer-Primary Peritoneal Cavity Cancer
January 2001
Phase 2
View MoreCollapse
References